23
total announcements
BETA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,743 Cr
P/E (TTM)
25.3
EPS (TTM)
₹67.90
52W Low
₹990.10
52W High
₹2,807.90
Dividend Yield
0.00%
Beta
-0.37
Price / Book
7.1
Debt / Equity
60.4
Revenue (TTM)
₹410 Cr
Gross Margin
57.10%
Operating Margin
18.34%
Beta Drugs Limited
Beta Drugs Limited has announced its Q1FY27 results, with a 25.3% increase in consolidated total sales to Rs 125.55 crores and a 40.92% growth in net profit to Rs 16.5 crores.
Beta Drugs Limited
Beta Drugs Limited has received a confirmation certificate from MUFG Intime India Private Limited regarding the dematerialization of securities and listing on stock exchanges.
Beta Drugs Limited
Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.